BioLife Solutions, Inc. (BLFS)
NASDAQ: BLFS · Real-Time Price · USD
24.51
+0.51 (2.13%)
Mar 3, 2025, 4:00 PM EST - Market closed
BioLife Solutions Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Revenue | 82.25 | 143.27 | 161.76 | 119.16 | 48.09 | Upgrade
|
| Revenue Growth (YoY) | -42.59% | -11.43% | 35.75% | 147.79% | 75.69% | Upgrade
|
| Cost of Revenue | 28.58 | 96.52 | 107.69 | 80.98 | 20.24 | Upgrade
|
| Gross Profit | 53.67 | 46.75 | 54.07 | 38.18 | 27.85 | Upgrade
|
| Selling, General & Admin | 50.15 | 80.31 | 69.24 | 47.67 | 21.69 | Upgrade
|
| Research & Development | 7.91 | 18.8 | 14.8 | 11.82 | 6.72 | Upgrade
|
| Operating Expenses | 60.8 | 104.29 | 93.74 | 67.7 | 31.44 | Upgrade
|
| Operating Income | -7.13 | -57.53 | -39.66 | -29.52 | -3.59 | Upgrade
|
| Interest Expense | -0.72 | -1.81 | -0.69 | -0.49 | - | Upgrade
|
| Interest & Investment Income | - | - | - | - | 0.04 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.5 | 1.26 | 0.7 | 0.17 | 3.6 | Upgrade
|
| EBT Excluding Unusual Items | -7.35 | -58.08 | -39.65 | -29.84 | 0.05 | Upgrade
|
| Merger & Restructuring Charges | - | - | -0.27 | -2.77 | -1.08 | Upgrade
|
| Gain (Loss) on Sale of Investments | -4.07 | - | 0.7 | - | 1.32 | Upgrade
|
| Asset Writedown | - | -15.49 | -110.36 | - | - | Upgrade
|
| Other Unusual Items | - | 7.31 | 4.75 | 3.58 | -1.58 | Upgrade
|
| Pretax Income | -11.43 | -66.26 | -144.83 | -29.03 | -1.28 | Upgrade
|
| Income Tax Expense | -0.04 | 0.17 | -5.02 | -20.12 | -3.26 | Upgrade
|
| Earnings From Continuing Operations | -11.39 | -66.43 | -139.81 | -8.91 | 1.98 | Upgrade
|
| Earnings From Discontinued Operations | -8.8 | - | - | - | - | Upgrade
|
| Net Income to Company | -20.18 | -66.43 | -139.81 | -8.91 | 1.98 | Upgrade
|
| Net Income | -20.18 | -66.43 | -139.81 | -8.91 | 1.98 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | - | - | - | 0.16 | Upgrade
|
| Net Income to Common | -20.18 | -66.43 | -139.81 | -8.91 | 1.82 | Upgrade
|
| Shares Outstanding (Basic) | 46 | 44 | 42 | 39 | 27 | Upgrade
|
| Shares Outstanding (Diluted) | 46 | 44 | 42 | 39 | 27 | Upgrade
|
| Shares Change (YoY) | 5.37% | 2.91% | 10.33% | 41.01% | 40.32% | Upgrade
|
| EPS (Basic) | -0.44 | -1.52 | -3.29 | -0.23 | 0.07 | Upgrade
|
| EPS (Diluted) | -0.44 | -1.52 | -3.29 | -0.23 | -0.06 | Upgrade
|
| Free Cash Flow | 8.43 | -23.74 | -22.41 | -19.35 | -1.16 | Upgrade
|
| Free Cash Flow Per Share | 0.18 | -0.54 | -0.53 | -0.50 | -0.04 | Upgrade
|
| Gross Margin | 65.25% | 32.63% | 33.43% | 32.04% | 57.92% | Upgrade
|
| Operating Margin | -8.67% | -40.16% | -24.52% | -24.77% | -7.46% | Upgrade
|
| Profit Margin | -24.54% | -46.36% | -86.43% | -7.48% | 3.79% | Upgrade
|
| Free Cash Flow Margin | 10.25% | -16.57% | -13.85% | -16.24% | -2.42% | Upgrade
|
| EBITDA | -4.39 | -45.24 | -23.19 | -16.65 | 1.48 | Upgrade
|
| EBITDA Margin | -5.34% | -31.58% | -14.34% | -13.98% | 3.08% | Upgrade
|
| D&A For EBITDA | 2.74 | 12.3 | 16.47 | 12.87 | 5.07 | Upgrade
|
| EBIT | -7.13 | -57.53 | -39.66 | -29.52 | -3.59 | Upgrade
|
| EBIT Margin | -8.67% | -40.16% | -24.52% | -24.77% | -7.46% | Upgrade
|
| Revenue as Reported | 82.25 | 143.27 | 161.76 | 119.16 | 48.09 | Upgrade
|
| Advertising Expenses | - | 1.5 | 0.8 | 0.6 | 0.17 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.